The Small CPI Print Isn't What Moves Celanese. Paying Off Its Debt Is.

A single August inflation reading has been set up to tip the Federal Reserve toward a quarter-point rate hike at its meeting the week of September 15 — the kind of coin-flip that makes a whole market hold its breath. For a heavily borrowed chemical maker like Celanese (NYSE: CE), the knee-jerk reaction is to treat that as the entire story: lower rates and the world changes, a hike and the pain deepens. That instinct is backwards for this company, which is why its next twelve months may turn out better than its tape has lately suggested.

First, the pain, stated plainly. Celanese borrowed heavily to buy DuPont's mobility-and-materials business in 2022, raising $7.5 billion of financing at an effective rate near 5.6%. Through a weak chemical cycle, the leverage backfired. The company slashed its dividend by roughly 95%, and in August 2025 Fitch downgraded it to BB+ — below investment grade — warning that leverage would stay above 4x for years. Today the stock trades near $45, about 35% below its 52-week high, carrying roughly $16.8 billion of total debt against about $4.6 billion of equity. The old story writes itself: a hostage to interest rates, one hot print away from trouble.

The headlines say that. The cash-flow path says otherwise.

The quarter that flipped the narrative

In early August, Celanese reported its best adjusted earnings per share in years: $2.45 for the second quarter, ahead of the roughly $2.23 analysts had expected. Just as important, it took free cash flow up to its full-year target of $700–800 million and repaid $508 million of bonds in the quarter, with about $900 million of repayments planned through the third quarter. Free cash flow over the trailing twelve months had already turned up, growing about 12% year over year to roughly $700 million.

That is the single number that matters, and a beginner's instinct is to undersell it. Free cash flow is what's left after a company has paid its workers, its suppliers, its taxes, and reinvested in the plants it needs to run. It is the cash a company actually gets to decide what to do with. Celanese's headline earnings have wobbled from quarter to quarter (one down quarter can look scary), but the cash being thrown off is both positive and rising. The selloff matters less than the fact that expectations have already reset while the numbers have not broken.

Why debt paydown does the work a Fed cut can't

Here is the mechanism that makes the CPI debate the wrong lens. Celanese expects roughly $640 million of net cash interest in 2026 — nearly as large as its entire free cash flow target. That overlap is the whole story. Every dollar of debt repaid is an annual saving on interest, and every saving lifts free cash flow, which funds the next repayment. It is a flywheel that runs on the company's own results, not on Washington.

Management guided net debt to fall from the current ~$10.6 billion to around $9 billion by 2027, with a long-term goal of just 3x leverage. Paying that debt down shrinks the portion of the business that is hostage to whatever rate the next CPI print implies. A Fed hike raises the cost of the small piece left to refinance, but it cannot reverse the principal that is already paid off. For this stock, the durable improvement is the debt coming down — independent of the September coin-flip.

At roughly $5 billion in market value, guided free cash flow of $700–800 million is about a 15% cash yield, and the forward price-to-earnings multiple sits near 14x. Cheapness alone is never proof — a depressed multiple can just reflect permanent decline. What makes it more than cheap is that the cash so far this year has actually shown up, and the company is using a chunk of it to shrink the very thing investors are worried about.

What would prove the case wrong

None of this is a clean straight line, and candor requires saying so. Management guided third-quarter earnings down to $135–175 million — a step back from the second quarter's strength — and working capital has consumed roughly $300 million so far this year. The junk-level credit rating means refinancing risk is real, and a hike genuinely raises the cost of the debt that remains. This is a marathon, not a sprint, and I can be wrong again.

So treat the proof path as concrete. The case works if free cash flow keeps delivering at the $700–800 million level and net debt keeps falling toward that $9 billion target for 2027. It is broken the moment those two stop cooperating: if free cash flow guidance is missed, or if deleveraging stalls and the company has to lean back on its credit line. Then the old story — a levered cyclical exposed to rates it can't control — is right, and the discipline is to cut without ego.

The Fed will meet and the inflation reading will be forgotten within a month. The question worth checking next quarter is whether Celanese's cash keeps doing the one thing no interest-rate decision can do for a leveraged company: shrink the debt, and with it the whole rate conversation.

That is a setup a retail investor can actually evaluate — no rate forecasting required.